DNMT3A mutations in patients with acute myeloid leukemia in South Brazil

Advances in Hematology

Volumn 2012, Issue , 2012, Pages

  Pezzi, Annelise ^a,b   Moraes, Lauro ^a   Valim, Vanessa ^a,b   Amorin, Bruna ^a   Melchiades, Gabriela ^a   Oliveira, Fernanda ^a   Da Silva, Maria Aparecida ^a,b   Matte, Ursula ^a   Pombo De Oliveira, Maria S ^c   Bittencourt, Rosane ^a   Daudt, Liane ^a   Silla, Lúcia ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW; BRAZIL; CHROMOSOME TRANSLOCATION; DECISION MAKING; FEMALE; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION;

EID: 84870207341     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2012/697691     Document Type: Article

References (34)

1. Fröhling S., Scholl C., Gilliland D. G., Levine R. L., Genetics of myeloid malignancies: pathogenetic and clinical implications. Journal of Clinical Oncology 2005 23 26 6285 6295 2-s2.0-27244452986 10.1200/JCO.2005.05. 010 (Pubitemid 46218838)
2. Brunning and R. D., Classification of acute leukemias. Seminars in Diagnostic Pathology 2003 20 142 153 (Pubitemid 37169761)
3. Szczepanski T., van Velden V. H. J., van Dongen J. J. M., Classification systems for acute and chronic leukemias. Best Practice & Research Clinical Haematology 2003 16 561 582
4. Peter T., Andrew H., The epigenomics revolution in myelodysplasia: a clinic-pathological perspective. Hematopathology 2011 43 536 546
5. Plass C., Oakes C., Blum W., Marcucci G., Epigenetics in acute myeloid leukemia. Seminars in Oncology 2008 35 4 378 387 2-s2.0-48749122610 10.1053/j.seminoncol.2008.04.008
6. Galm O., Wilop S., Lüders C., Jost E., Gehbauer G., Herman J. G., Osieka R., Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Annals of Hematology, Supplement 2005 84 13 39 46 2-s2.0-29144469286 10.1007/s00277-005-0005-0
7. Boultwood J., Wainscoat J. S., Gene silencing by DNA methylation in haematological malignancies. British Journal of Haematology 2007 138 1 3 11 2-s2.0-34249982046 10.1111/j.1365-2141.2007.06604.x (Pubitemid 46889779)
8. Jones P. A., Baylin S. B., The epigenomics of cancer. Cell 2007 128 4 683 692 2-s2.0-33847065486 10.1016/j.cell.2007.01.029 (Pubitemid 46273572)
9. Ley T. J., Ding L., Walter M. J., McLellan M. D., Lamprecht T., Larson D. E., Kandoth C., Payton J. E., Baty J., Welch J., Harris C. C., Lichti C. F., Townsend R. R., Fulton R. S., Dooling D. J., Koboldt D. C., Schmidt H., Zhang Q., Osborne J. R., Lin L., O'Laughlin M., McMichael J. F., Delehaunty K. D., McGrath S. D., Fulton L. A., Magrini V. J., Vickery T. L., Hundal J., Cook L. L., Conyers J. J., Swift G. W., Reed J. P., Alldredge P. A., Wylie T., Walker J., Kalicki J., Watson M. A., Heath S., Shannon W. D., Varghese N., Nagarajan R., Westervelt P., Tomasson M. H., Link D. C., Graubert T. A., DiPersio J. F., Mardis E. R., Wilson R. K., DNMT3A mutations in acute myeloid leukemia. The New England Journal of Medicine 2010 363 25 2424 2433 2-s2.0-78649906060 10.1056/NEJMoa1005143
10. Yamashita Y., Yuan J., Suetake I., Suzuki H., Ishikawa Y., Choi Y. L., Ueno T., Soda M., Hamada T., Haruta H., Takada S., Miyazaki Y., Kiyoi H., Ito E., Naoe T., Tomonaga M., Toyota M., Tajima S., Iwama A., Mano H., Array-based genomic resequencing of human leukemia. Oncogene 2010 29 25 3723 3731 2-s2.0-77954089584 10.1038/onc.2010.117
11. Yan X. J., Xu J., Gu Z. H., Pan C. M., Lu G., Shen Y., Shi J. Y., Zhu Y. M., Tang L., Zhang X. W., Liang W. X., Mi J. Q., Song H. D., Li K. Q., Chen Z., Chen S. J., Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genetics 2011 43 4 309 315 2-s2.0-79953176952 10.1038/ng.788
12. Ribeiro A. F., Pratcorona M., Erpelinck-Verschueren C., Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood 2012 119 5824 5831
13. Patel J. P., Gönen M., Figueroa M. E., Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. The New England Journal of Medicine 2012 366 12 1079 1089
14. Thol F., Damm F., Lüdeking A., Winschel C., Wagner K., Morgan M., Yun H., Göhring G., Schlegelberger B., Hoelzer D., Lübbert M., Kanz L., Fiedler W., Kirchner H., Heil G., Krauter J., Ganser A., Heuser M., Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. Journal of Clinical Oncology 2011 29 21 2889 2896 2-s2.0-79960735923 10.1200/JCO.2011.35.4894
15. Marcucci G., Metzeler K. H., Schwind S., Age related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. Journal of Clinical Oncology 2012 30 7 742 750
16. Renneville A., Boissel N., Nibourel O., Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia 2011 26 6 1247 1254
17. Swerdlow S. H., Campo E., Harris N. L., WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues 2008 Lyon, France International Agency for Research on Cancer (IARC)
18. Van Dongen J. J. M., Macintyre E. A., Gabert J. A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Diáz M. G., Malec M., Langerak A. W., San Miguel J. F., Biondi A., Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999 13 12 1901 1928 2-s2.0-0032757710
19. Mitterbauer G., Zimmer C., Fonatsch C., Haas O. A., Thalhammer-Scherrer R., Schwarzinger I., Kalhs P., Jaeger U., Lechner K., Mannhalter C., Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR. Leukemia 1999 13 10 1519 1524 2-s2.0-0032827785 (Pubitemid 29465613)
20. Jácomo R. H., Melo R. A. M., Souto F. R., De Mattos E. R., De Oliveira C. T., Fagundes E. M., Bittencourt H. N. D. S., Bittencourt R. I., Bortolheiro T. C., Paton E. J. A., Bendlin R., Ismael S., Chauffaille M. D. L., Silva D., Pagnano K. B. B., Ribeiro R., Rego E. M., Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica 2007 92 10 1431 1432 2-s2.0-36348961330 10.3324/haematol.10874 (Pubitemid 350144166)
21. Capra M., Vilella L., Pereira W. V., Coser V. M., Fernandes M. S., Schilling M. A., Almeida D., Gross M., Leite M., Hellwig T., Natchigal G., Zelmanowicz A., Paskulin G., Neumann J., Silla L., Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil. Leukemia and Lymphoma 2007 48 12 2381 2386 2-s2.0-37149030594 10.1080/10428190701713622 (Pubitemid 350253469)
22. Phekoo K. J., Richards M. A., Moller H., Schey S. A., The incidence and outcome of myeloid malignancies in 2,112 adult patients in south East-England. Haematologica 2006 91 10 1400 1404 2-s2.0-33750020532 (Pubitemid 44569817)
23. Douer D., Preston-Martin S., Chang E., Nichols P. W., Watkins K. J., Levine A. M., High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 1996 87 1 308 313 2-s2.0-0030070668 (Pubitemid 26011845)
24. Schoch C., Haase D., Haferlach T., Gudat H., Büchner T., Freund M., Link H., Lengfelder E., Wandt H., Sauerland M. C., Löffler H., Fonatsch C., Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22 q22): an additional deletion in 9q is an adverse prognostic factor. Leukemia 1996 10 8 1288 1295 2-s2.0-9344237642 (Pubitemid 26261424)
25. Chauffaille M. F., Borri D., Martins S. R., Leucemia mielóide aguda t(8;21): freqüência em pacientes brasileiros. Revista Brasileira de Hematologia e Hemoterapia 2004 26 2 99 103
26. Arber D. A., Brunning R. D., Le Beau M. M., Swerdlow S. H., Campo E., Harris N. L., Acute myeloid leukaemia with recurrent genetic abnormalities. WHO classification of tumours of haematopoietic and lymphoid tissues 2008 4th Lyon IARC Press 110 23
27. Schoch C., Haferlach T., Cytogenetics in acute myeloid leukemia. Current Oncology Reports 2002 4 5 390 397 2-s2.0-0036717446
28. Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C. J., Wheatley K., Burnett A. K., Goldstone A. H., The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001 98 5 1312 1320 2-s2.0-0035469883 10.1182/blood.V98.5.1312
29. Look A. T., Oncogenic transcription factors in the human acute leukemias. Science 1997 278 5340 1059 1064 2-s2.0-0030658039 10.1126/science.278.5340.1059 (Pubitemid 27517875)
30. Stegelmann F., Bullinger L., Schlenk R. F., Paschka P., Griesshammer M., Blersch C., Kuhn S., Schauer S., Döhner H., Döhner K., DNMT3A mutations in myeloproliferative neoplasms. Leukemia 2011 25 7 1217 1219 2-s2.0-79960210747 10.1038/leu.2011.77
31. Marková J., Michková P., Burèková K., Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia. European Journal of Haematology 2012 88 2 10 128 10.1111/j.1600-0609.2011.01716.x
32. Thol F., Winschel C., Lüdeking A., Rare occurrence of DNMT3A mutations in myelodysplastic syndromes. Haematologica 2011 96 12 1870 1873
33. Lin J., Dm Y., Qian J., Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS ONE 2011 6 10 e26906 10.1371/journal.pone.0026906
34. Thiede C., Mutant DNMT3A: teaming up to transform. Blood 2012 119 24 56157